Caroline Dumolyn Selected Research

14C5 monoclonal antibody

4/2013	Generation and in vivo characterization of a chimeric αvβ5-targeting antibody 14C5 and its derivatives.
4/2010	Preclinical evaluation of monoclonal antibody 14C5 for targeting pancreatic cancer.
12/2008	Monoclonal antibody 14C5 targets integrin alphavbeta5.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Caroline Dumolyn Research Topics

Disease

4	Neoplasms (Cancer) 04/2013 - 12/2008
1	Rheumatoid Arthritis 12/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2010
1	Lung Neoplasms (Lung Cancer) 12/2008
1	Carcinoid Tumor (Carcinoid) 12/2008
1	Carcinoma (Carcinomatosis) 12/2008

Drug/Important Bio-Agent (IBA)

3	14C5 monoclonal antibodyIBA 04/2013 - 12/2008
2	Monoclonal AntibodiesIBA 04/2013 - 04/2010
2	integrin alphaVbeta5IBA 04/2010 - 12/2008
2	AntigensIBA 08/2009 - 12/2008
1	Certolizumab Pegol FDA Link 12/2016
1	1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenylglycolurilIBA 04/2013
1	IntegrinsIBA 04/2013
1	Radioisotopes (Radionuclides)IBA 04/2010
1	AntibodiesIBA 04/2010

Therapy/Procedure

3	Therapeutics 04/2010 - 12/2008
1	Radioimmunotherapy 04/2013
1	Immunotherapy 08/2009